| Similar Articles |
|---|
 |
BusinessWeek
April 28, 2011
Ashlee Vance |
Pacific Biosciences' $600 Million Decoder Ring Pacific Biosciences' technology may finally fulfill the dream of gene sequencing.   |
Chemistry World
May 29, 2014
Hepeng Jia |
Chinese-made DNA sequencer aims to challenge foreign dominance With an independently developed next-generation DNA sequencer, Chinese scientists are aiming to challenge the dominance of international players in the world's fastest growing genome sequencing market. |
BusinessWeek
October 23, 2008
John Carey |
Reading the Entire Genetic Code Pioneers such as 23andMe and Navigenics use snips of genes to make medical predictions. Now new tools from more start-ups are on the horizon. |
The Motley Fool
August 12, 2009
Brian Orelli |
The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing. |
The Motley Fool
August 18, 2010
Luke Timmerman |
Life Technologies Competes for Cheap DNA Sequencing In the race to cheaper gene sequencing. |
The Motley Fool
December 31, 2010
Brian Orelli |
3 Biotech 2010 IPOs Worthy of a Look These IPOs are worth a spot on your watchlist. |
The Motley Fool
January 14, 2010
Brian Orelli |
$1,000 Genomes, Here We Come Illumina jumps on news of its $10,000 genome. |
The Motley Fool
April 27, 2011
Brian Orelli |
Illuminating the Growth Competition in the DNA sequencing market may be heating up, but 47% growth for Illumina isn't too shabby. |
Chemistry World
February 21, 2012
Phillip Broadwith |
Nanopore sequencing bags its first genome Oxford Nanopore has presented the first complete genome to be sequenced using a nanopore. |
IEEE Spectrum
March 2013
Eliza Strickland |
The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine |
Bio-IT World
April 2006
Karen Hopkin |
AGBT Meeting Puts Genome Advances Front and Center If the presentations at February's Advances in Genome Biology and Technology (AGBT) are any indication, the race to generate fresh approaches to produce more sequence for less is far from over -- and looks to be heating up. |
Bio-IT World
September 2005
Kevin Davies |
Fantastic 454: DNA Sequencing Pyrotechnics In an exciting advance for DNA sequencing technology, a research team at 454 Life Sciences Corp. has essentially sequenced and assembled a bacterial genome sequence based on a mere 4-hour run on the company's proprietary instrument. |
Bio-IT World
October 2005
Dennis A. Gilbert |
The DNA Sequencing Race: From Sprint to Marathon To create faster, cheaper, and better solutions for DNA analysis, we must remain committed to improving both current and new sequencing technologies. Research that just a short while ago might have been considered too complex, too expensive, or just inconceivable is now well within our grasp. |
The Motley Fool
August 19, 2011
Alexander Crawford |
DNA Sequencing: The Next High-Growth Market in Biotech? We compiled a list of companies with a hand in the DNA sequencing market. Should you add these companies to your watch list? |
Bio-IT World
November 19, 2004
John Russell |
GSAC Rolls On Genome Sequencing and Analysis Conference rolls on... Stephen Quake discusses research on single-molecule DNA sequencing by synthesis... A photocleavable fluorescent nucleotide for DNA sequencing and analysis... |
Bio-IT World
April 15, 2003
James Golden |
Sequence Signatures and Homeland Security The bio-IT community has a unique opportunity to contribute to national biodefense. |
Popular Mechanics
April 25, 2008
Erik Sofge |
Inside the Forgotten X Prize--the One That Can Save Your Life An extensive look at the Archon X Prize in Genomics, the $10 million race for a cheap, disease-hunting gene sequencer that could land on your kitchen counter sooner than you think. |
Bio-IT World
November 14, 2003
Julia Boguslavsky |
Genome Center in a Box Scientists at 454 Life Sciences developed an integrated end-to-end instrument that performs hundreds of thousands of reactions in parallel -- from sample preparation, amplification, and sequencing to data storage and bioinformatics. |
The Motley Fool
February 8, 2010
Brian Orelli |
An Earnings Surprise of an Unusual Kind Illumina beats management's own preliminary revenue announcement. |
The Motley Fool
January 3, 2012
Alex Planes |
Another Entry in the Genome Patent Rumble There's a whole lot of lawsuits going on. |
| Knowledge@Wharton |
From Skin Creams to Life Insurance to Medical Care, Biosciences Are the New Frontier of Business Opportunity Research in the biological sciences holds the potential for breakthroughs that could transform the world. But scientific advances also can be baffling and more than a little intimidating, especially for business people... |
The Motley Fool
November 17, 2006
Jack Uldrich |
Neanderthal DNA Enlightens Investors Investors, the superb performance of 454's gene sequencing equipment on such a difficult and important project bodes well for its future prospects. |
The Motley Fool
September 28, 2006
Jack Uldrich |
Is CuraGen Hiding a Genomic Gem? A majority ownership stake in 454 Life Sciences could pay hefty dividends. |
The Motley Fool
July 24, 2008
Brian Orelli |
Illumina Polishes Its Biochips There's very little to complain about in Illumina's earnings report. In this market, you'll see few investors grumbling about double-digit growth. |
Bio-IT World
May 2006
Kevin Davies |
Interpreting Genes and Genomes From microarrays to sequencing technology, molecular diagnostics to the interactome, this year's Bio-IT World Conference showcased exciting advances in genome technology applications, in which software analysis and data management play critical roles. |
IEEE Spectrum
June 2009
Prachi Patel |
Advance in Nanopore Gene Sequencing Magnets help in the quest for the $1000 genome |
Chemistry World
January 27, 2012
Sarah Houlton |
Illumina fends off Roche hostile bid Roche has made a $5.7 billion hostile bid for the genome sequencing company Illumina, after the San Diego, US-based company rejected its initial approach. |
HHMI Bulletin
May 2012
Sarah C. P. Williams |
Opening the Floodgates Researchers are using exome sequencing -- zeroing in on the genes that encode proteins -- to explore the biology of certain diseases. |
Bio-IT World
February 2006
Kevin Davies |
Solexa Readies 1G Genetic Analyzer Solexa, one of the firms vying to crack the $1,000 genome threshold, has officially launched its first commercial genome sequencing instrument. |
IEEE Spectrum
March 2013
Susan Hassler |
Genome to Go It's already possible to have your own genome sequenced. But personalized medicine based on sequencing still has a way to go |
The Motley Fool
October 28, 2009
Brian Orelli |
Ugly, but Still Built for Growth It continues to be a tale of two business segments for Illumina, with sales from the consumables used in its sequencing machines more than doubling, while its array business remains down considerably. |
Chemistry World
April 19, 2013
Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
Chemistry World
July 21, 2011
James Mitchell Crow |
Sequencing Chip Decodes DNA Proton by Proton Technology that can directly detect the chemical reaction as a single nucleotide adds to the end of a growing strand of DNA is about to slash the cost of genome sequencing, its inventors say. |
Bio-IT World
October 2006
Kevin Davies |
Cracking the Cancer Genome Regardless of which technologies win out, or which centers win the lucrative sequencing contracts, the Cancer Genome Atlas has a sublime medical and scientific importance, underscored by the latest findings from Hopkins. |
Chemistry World
April 3, 2008
Lewis Brindley |
DNA Read in a Trice The prospect of treatments that are tailored to fit an individual's genetic makeup is a step closer thanks to technology unveiled by US scientists. |
The Motley Fool
May 28, 2010
Brian Orelli |
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. |
The Motley Fool
March 30, 2007
Ralph Casale |
Another Genetic Sequencer Gobbled Up Roche buys out second-generation sequencer 454 Life Sciences. Investors, take note. |
The Motley Fool
July 28, 2010
Brian Orelli |
Now There's an Illuminating Idea Helping your customers sell more of your product makes a lot of sense. |
Bio-IT World
October 2006
Michael A. Greeley |
What Use Is the $1,000 Genome? Industry is focused on the $1,000 genome -- but investors want to see revenue and profits. The goal of simply reaching the $1,000 genome threshold inherently lacks a business model. What are the applications or products or services that will be unleashed by reaching that milestone? |
The Motley Fool
May 23, 2011
Tim Beyers |
2 Must-Own Tech Stocks and 1 to Watch Two Motley Fool analysts take a trip to Silicon Valley and come away with these new technology stock ideas: Riverbed Technologies... Pacific Biosciences... |
Bio-IT World
August 13, 2003
Michael Greeley |
Two Cents on the '$1,000 Genome' Are venture capitalists still looking for 'the killer app'? Funding the next big idea won't be so easy. Affordable, individualized genome sequencing holds great promise, but making the claims sound too grandiose can be dangerous. |
The Motley Fool
July 22, 2009
Brian Orelli |
Levering the Genome Lower revenue can't stop Illumina from turning in a good bottom line. |
The Motley Fool
July 6, 2010
Luke Timmerman |
Amazon Sees the Future of Biology in the Cloud Amazon Web Services is helping life sciences companies. |
Bio-IT World
January 13, 2003
Julia Boguslavsky |
A Sequel to the Sequence The all-but-complete human genome sequence is not only an indispensable tool for biomedical research but also a major influence on the types of instrumentation researchers will invest in. |
Chemistry World
August 22, 2014
Phillip Broadwith |
Illumina targets cancer diagnostics Genetic sequencing heavyweight Illumina has partnered with three major pharmaceutical firms in a bid to develop a universal sequencing-based oncology test system. |
IEEE Spectrum
July 2010
Prachi Patel |
Computing the Neanderthal Genome New software helped decode the DNA of our stone-age cousins |
